• Addressing a large patient group in need of new treatment alternatives
• Phase I to be concluded in 2024
• We initiate coverage with a fair value of
Chronic inflammation, such as rheumatoid arthritis, affects millions of people globally. Available treatment options are often insufficient and new approaches are much needed. Umeå-based
Västra Hamnen initiates research coverage of
© Modular Finance, source